Virtu Financial LLC Accelerate Diagnostics, Inc Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.51 - $17.1 $8,905 - $298,583	17,461 Added 95.36%	35,771 $25,000
Q3 2022 Nov 07, 2022	BUY	$1.01 - $17.0 $18,493 - $311,270	18,310 New	18,310 $28,000
Q1 2021 May 19, 2021	SELL	$7.99 - $15.0 $89,823 - $168,630	-11,242 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$7.04 - $11.7 $79,143 - $131,531	11,242 New	11,242 $85,000
Q3 2020 Dec 11, 2020	SELL	$9.98 - $18.04 $104,380 - $188,680	-10,459 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$7.49 - $15.16 $78,337 - $158,558	10,459 New	10,459 $159,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $168M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.